Patient-reported symptom burden and circulating cytokines undergoing chemotherapy: a pilot study in patients with ovarian cancer.

Ying Tang Yuan-Yuan Zhang Ming-Bo Weng Lin Li Hui-Quan Hu Yu-Hua Zeng Qiuling Shi

Published in: Journal of gynecologic oncology (2024)

MDASI-OC was feasible and adaptable for demonstrating the fluctuations of symptom burden throughout chemotherapy course. Moreover, symptoms changing along with cytokines levels could provide clues for exploring mechanism underlying biochemical etiology.

Keyphrases

patient reported
locally advanced
risk factors
squamous cell carcinoma
chemotherapy induced
radiation therapy
depressive symptoms